Alterity Therapeutics Receives U.S. FDA Approval for Investigational New Drug Application for ATH434 for the Treatment of Multiple System Atrophy September 20, 2022May 23, 2023
Alterity participates in world’s largest virtual healthcare conference JP Morgan January 11, 2021August 16, 2022
